SES Swaps SES-12 and SES-14 Launches
SES today announced a change of launch vehicles and launch slots for its SES-12 and SES-14 satellites. Under the new agreements, SES-12 will be launched on a Falcon 9 vehicle from SpaceX in Q1 2018 while SES-14 will be launched on an Ariane 5 rocket early in Q1 2018. The swap of launches will enable SES to improve service quality and continuity for its customers. Both SES-12 and SES-14 are using electric propulsion for orbit-raising and will enter into service some four to six months after launch.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170827005093/en/
SES-14, manufactured by Airbus Defense and Space, will be positioned at the 47.5 degrees West orbital slot. The C-band payload of SES-14 will replace NSS-806 and will support SES’s cable neighborhood in Latin America. The Ku-band payload augments the Ku-band capacity on NSS-806 with wide beams and high throughput spot beams covering the Americas and the North Atlantic Region. The Ku-band spot beams will allow SES to support the increasing demand for aeronautical and maritime mobility applications, cellular backhaul, broadband delivery, and VSAT services for enterprise and government segments. The Ku-band wide beams are designed to provide video and data services in Latin America, the Caribbean, and across the North Atlantic. SES-14 also carries the Global-Scale Observations of the Limb and Disk (GOLD) as a hosted payload for NASA.
SES-12, a very large satellite also manufactured by Airbus Defense and Space, will be positioned at 95 degrees East. The satellite will expand SES’s capabilities to provide direct-to-home (DTH) broadcasting, VSAT, Mobility and HTS data connectivity services in the Middle East and the Asia-Pacific region, including rapidly growing markets such as India and Indonesia. The satellite will replace NSS-6 at this location and will be co-located with SES-8. As the largest satellite ever built for SES, SES-12 is capable of supporting requirements in multiple verticals from Cyprus in the West to Japan in the East, and from Russia in the North to Australia in the South.
Follow us on:
SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 12 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes ASTRA, O3b Networks and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (ticker: SESG). Further information available at: www.ses.com
Corporate Communications & PR
Tel. +352 710 725 500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum